Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK IPV versus Chinese OPV primary vaccination in healthy infants in China
2011-003167-30Phase 3
- Sponsor
- GSK
- Start
- Apr 2015
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in poliomyelitis comparing GSK IPV with Chinese OPV (2 arms). Primary endpoint: Anti-poliovirus types 1, 2 and 3 seroprotection status.
02
Drugs
trivalent inactivated polio vaccinepoliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on 2011-003167-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003167-30.